Reuters logo
BRIEF-‍Kirin-Amgen joint venture to become wholly-owned subsidiary of Amgen​
October 31, 2017 / 6:46 AM / 25 days ago

BRIEF-‍Kirin-Amgen joint venture to become wholly-owned subsidiary of Amgen​

Oct 31 (Reuters) - Amgen Inc

* ‍Kirin-Amgen joint venture to become wholly-owned subsidiary of Amgen​

* ‍Under terms of agreement, ‍Kirin-Amgen joint venture will pay $780 million to Kirin​

* ‍Kirin-Amgen will become a wholly-owned subsidiary of Amgen​

* ‍Joint venture ‍Kirin-Amgen will redeem Kirin’s shares ​

* ‍Will make additional payments to Kirin upon occurrence of certain sales​

* ‍As sole shareholder of ‍Kirin-Amgen, Amgen will own product rights and remaining cash held by ‍Kirin-Amgen

* ‍License agreements between ‍Kirin-Amgen and KHK in certain Asian territories will remain in place​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below